CORTICUS
Hydrocortisone therapy for patients with septic shock
On this page
Overview
Hydrocortisone hastened shock reversal but did not improve survival in CORTICUS.
Clinical takeaway
CORTICUS is the septic-shock steroid caution trial, best interpreted with APROCCHSS and ADRENAL when deciding steroid use for persistent vasopressor-dependent shock.
Key result
28-day mortality was not significantly reduced with hydrocortisone.
Practice impact
Steroids are for selected refractory septic shock, not routine sepsis treatment.
Evidence
Study design
Randomized, double-blind, placebo-controlled trial.
Enrollment
499
Follow-up
28 days for primary outcome.
Geography
Multinational
Clinical question
Does hydrocortisone improve survival in septic shock, and does response depend on corticotropin testing?
Population
- Adults with septic shock.
Intervention
Hydrocortisone.
Comparator
Placebo.
Primary outcome
28-day mortality among patients without a response to corticotropin.
Hydrocortisone did not significantly reduce 28-day mortality in septic shock.
Between-group comparison / p=not significant
Key results
- 28-day mortality was not significantly reduced.
- Shock reversal occurred faster with hydrocortisone.
- Superinfection and hyperglycemia were more common concerns.
Harms
- Hyperglycemia, hypernatremia, and superinfection are practical steroid harms.
Clinical Use
When to cite
- When discussing why septic-shock steroid evidence is mixed and patient selection matters.
Practice impact
- Helped move practice away from routine corticotropin testing to guide septic-shock steroids.
Applicability
- Septic shock patients where steroid use is being considered for persistent vasopressor need.
Limitations
- Underpowered after early stopping and enrolled less-severe shock than some other steroid trials.
- Does not exclude hemodynamic benefit.
Common misinterpretations
- Do not cite CORTICUS as proof steroids never help; shock reversal improved and later trials add nuance.
Related evidence
Citation
Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111-124. doi:10.1056/NEJMoa071366
- PMID
- 18184957